亚洲 · 区域市场 · CNBC-TV18
Dr Reddy's gets DGCI clearance for Zytorvi; Here's how company shares reacted
Dr Reddy's Laboratories received DCGI approval for Zytorvi to treat advanced oesophageal squamous cell carcinoma in India.
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.cnbctv18.com)




